ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Testosterone use in postmenopausal women
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 182777" data-attributes="member: 13851"><p><strong>ABSTRACT</strong></p><p></p><p>The physiological, clinical, and therapeutic aspects of testosterone in women’s health are still a matter of controversy and debate. <em><span style="color: rgb(184, 49, 47)">Quality evidence data of clinical trials favor the use of transdermal testosterone in postmenopausal women with female sexual dysfunction causing distress. Doses of testosterone should approximate physiological testosterone levels found in premenopausal women, avoiding supraphysiological concentrations that expose women to adverse events. </span></em>Short-term treatment periods have been shown to be effective and safe in postmenopausal women with hypoactive sexual desire disorder/dysfunction. However, the long-term safety of testosterone use must be determined.</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><em><strong><span style="color: rgb(184, 49, 47)">In conclusion, transdermal testosterone therapy has been demonstrated to be effective and safe in well-powered clinical trials for the treatment of HSDD in postmenopausal women, when doses used approximate physiological testosterone levels in premenopausal women.</span></strong></em> <em><span style="color: rgb(44, 130, 201)"><strong>However, further research is needed to deepen our knowledge of the effects of testosterone therapy on cognitive performance, musculoskeletal and cardiovascular health, as well as longterm safety use. </strong></span></em></p></blockquote><p></p>
[QUOTE="madman, post: 182777, member: 13851"] [B]ABSTRACT[/B] The physiological, clinical, and therapeutic aspects of testosterone in women’s health are still a matter of controversy and debate. [I][COLOR=rgb(184, 49, 47)]Quality evidence data of clinical trials favor the use of transdermal testosterone in postmenopausal women with female sexual dysfunction causing distress. Doses of testosterone should approximate physiological testosterone levels found in premenopausal women, avoiding supraphysiological concentrations that expose women to adverse events. [/COLOR][/I]Short-term treatment periods have been shown to be effective and safe in postmenopausal women with hypoactive sexual desire disorder/dysfunction. However, the long-term safety of testosterone use must be determined. [I][B][COLOR=rgb(184, 49, 47)]In conclusion, transdermal testosterone therapy has been demonstrated to be effective and safe in well-powered clinical trials for the treatment of HSDD in postmenopausal women, when doses used approximate physiological testosterone levels in premenopausal women.[/COLOR][/B][/I] [I][COLOR=rgb(44, 130, 201)][B]However, further research is needed to deepen our knowledge of the effects of testosterone therapy on cognitive performance, musculoskeletal and cardiovascular health, as well as longterm safety use. [/B][/COLOR][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Testosterone use in postmenopausal women
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top